Airway epithelial cells are susceptible to infection with seasonal influenza A viruses (IAV), resulting in productive virus replication and release. Macrophages (M⌽) are also permissive to IAV infection; however, virus replication is abortive. Currently, it is unclear how productive infection of M⌽ is impaired or the extent to which seasonal IAV replicate in M⌽. Herein, we compared mouse M⌽ and epithelial cells for their ability to support genomic replication and transcription, synthesis of viral proteins, assembly of virions, and release of infectious progeny following exposure to genetically defined IAV. We confirm that seasonal IAV differ in their ability to utilize cell surface receptors for infectious entry and that this represents one level of virus restriction. Following virus entry, we demonstrate synthesis of all eight segments of genomic viral RNA (vRNA) and mRNA, as well as seven distinct IAV proteins, in IAV-infected mouse M⌽. Although newly synthesized hemagglutinin (HA) and neuraminidase (NA) glycoproteins are incorporated into the plasma membrane and expressed at the cell surface, electron microscopy confirmed that virus assembly was defective in IAV-infected M⌽, defining a second level of restriction late in the virus life cycle.
IMPORTANCE
Seasonal influenza A viruses (IAV) and highly pathogenic avian influenza viruses (HPAI) infect macrophages, but only HPAIreplicate productively in these cells. Herein, we demonstrate that impaired virus uptake into macrophages represents one level of restriction limiting infection by seasonal IAV. Following uptake, seasonal IAV do not complete productive replication in macrophages, representing a second level of restriction. Using murine macrophages, we demonstrate that productive infection is blocked late in the virus life cycle, such that virus assembly is defective and newly synthesized virions are not released. These studies represent an important step toward identifying host-encoded factors that block replication of seasonal IAV, but not HPAI, in macrophages.
In humans, infection with seasonal influenza A viruses (IAV) is generally restricted to the respiratory tract. IAV infection of airway epithelial cells (AEC) is initiated following recognition of cell surface sialic acid (SIA) by the viral hemagglutinin (HA) glycoprotein (reviewed in reference 1). In addition to HA-SIA binding, it is likely that particular membrane-associated glycoproteins and/or glycolipids facilitate virus entry into AEC; however, the identity of such an entry receptor(s) is currently unknown. IAV infection of AEC results in productive virus replication, characterized by synthesis of viral RNA (vRNA) and mRNA, production of viral proteins, virion assembly, and budding of viral progeny from the surfaces of infected cells. Productive infection of AEC results in amplification of IAV in the airways, promoting virus dissemination and disease.In addition to AEC, macrophages (M⌽) are one of the first cells in the respiratory tract to detect and respond to IAV. As for AEC, binding ...